Infectious Disease Clinics of North America volume 27, issue 4, P723-737 2013 DOI: 10.1016/j.idc.2013.08.001 View full text
|
|
Share
Lindley A. Barbee, Julia C. Dombrowski

Abstract: Neisseria gonorrhoeae has developed resistance to all previous first-line antimicrobial therapies recommended by the United States’ Centers for Disease Control and Prevention over the past 75 years. Now the cephalosporins, the last available antibiotic class that is sufficiently effective, economical, and feasibly delivered in the outpatient setting are also threatened by evolving resistance. Screening for asymptomatic gonorrhea in women and men who have sex with men, treating with a dual antibiotic regimen, …

expand abstract